Clinical Trial Update: Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 multicenter trial in Israel is evaluating D-Serine for schizophrenia and schizoaffective disorder. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Sheba Medical Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: UNKNOWN